Stivarga 50419-0171-03
Generic: Regorafenib
- Manufacturer
- Bayer Healthcare Pharmaceuticals Inc.
- Dosage Form
- Tablet, Film Coated
- Route
- Oral
- Product Type
- Human Prescription Drug
- Marketing Start
- September 27, 2012
- Listing Expires
- December 31, 2027
- Application
- NDA203085
Need to source Stivarga? Find it on a pharmacy-to-pharmacy marketplace at better prices.
✓ DSCSA Compliant. ✓ Verified Pharmacies Only.P2P pharmacy marketplace.
Active Ingredients
| Ingredient | Strength |
|---|---|
| Regorafenib | 40 mg/1 |
Drug Class
Breast Cancer Resistance Protein Inhibitors [MoA]Cytochrome P450 2C9 Inhibitors [MoA]Kinase Inhibitor [EPC]
Selected Package
50419-0171-03Selected3 BOTTLE, PLASTIC in 1 BOX (50419-171-03) / 28 TABLET, FILM COATED in 1 BOTTLE, PLASTIC (50419-171-01)
Other packages for this product(3)
210 BOTTLE in 1 BOX (50419-171-00) / 28 TABLET, FILM COATED in 1 BOTTLE
1 BOTTLE, PLASTIC in 1 CARTON (50419-171-04) / 28 TABLET, FILM COATED in 1 BOTTLE, PLASTIC
4 BOTTLE, PLASTIC in 1 CARTON (50419-171-06) / 21 TABLET, FILM COATED in 1 BOTTLE, PLASTIC (50419-171-05)